Prevalence and incidence of diabetes mellitus in adult patients on growth hormone replacement for growth hormone deficiency: A surveillance database analysis

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 7, 2011, Pages 2255-2261

  Attanasio, Andrea F ^a   Jung, Heike ^b   Mo, Daojun ^c   Chanson, Philippe ^d   Bouillon, Roger ^e   Ho, Ken K Y ^f   Lamberts, Steven W J ^g   Clemmons, David R ^h  

^a Cascina del Rosone ^*  (Italy)

^b LILLY DEUTSCHLAND GMBH   (Germany)

^c ELI LILLY AND COMPANY   (United States)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e UNIVERSITY OF LEUVEN   (Belgium)

^f ST VINCENT S HOSPITAL   (Australia)

^g ERASMUS MEDICAL CENTER   (Netherlands)

^h UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HUMAN GROWTH HORMONE; INSULIN;

ADULT; AGE; ARTICLE; BODY MASS; DATA BASE; DIABETES MELLITUS; EUROPE; FEMALE; GENDER; GROWTH HORMONE DEFICIENCY; HEALTH SURVEY; HUMAN; INCIDENCE; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; PRIORITY JOURNAL; UNITED STATES;

ADULT; DIABETES MELLITUS; EUROPE; FEMALE; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; UNITED STATES;

EID: 79960091085     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-0448     Document Type: Article

References (32)

1. Jeffcoate W 2002 Growth hormone therapy and its relationship to insulin resistance, glucose intolerance and diabetes mellitus: a review of recent evidence. Drug Saf 25:199-212 (Pubitemid 34492939)
2. Cutfield WS, Wilton P, Bennmarker H, Albertsson-Wikland K, Chatelain P, Ranke MB, Price DA 2000 Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment. Lancet 355:610-613 (Pubitemid 30099467)
3. Johansson JO, Fowelin J, Landin K, Lager I, Bengtsson BA 1995 Growth hormone-deficient adults are insulin-resistant. Metabolism 44:1126-1129 (Pubitemid 26084031)
4. Hew FL, Koschmann M, Christopher M, Rantzau C, Vaag A, Ward G, Beck-Nielsen H, Alford F 1996 Insulin resistance in growth hormone- deficient adults: defects in glucose utilization and glycogen synthase activity. J Clin Endocrinol Metab 81:555-564 (Pubitemid 26055663)
5. Johannsson G, Bengtsson BA 1999 Growth hormone and the metabolic syndrome. J Endocrinol Invest 22(5 Suppl):41-46
6. Attanasio AF, Mo D, Erfurth EM, Tan M, Ho KY, Kleinberg D, Zimmermann AG, Chanson P; International Hypopituitary Control Complications Study Advisory Board 2010 Prevalence of metabolic syndrome in adult hypopituitary growth hormone (GH)-deficient patients before and after GH replacement. J Clin Endocrinol Metab 95:74-81
7. Monson JP, Bengtsson BA, Abs R, Feldt-Rasmussen U, Wüster C 2000 Can growth hormone therapy cause diabetes? KIMS Strategic Committee. Lancet 355:1728-1729 (Pubitemid 30248499)
8. Svensson J, Fowelin J, Landin K, Bengtsson BA, Johansson JO 2002 Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults. J Clin Endocrinol Metab 87:2121-2127 (Pubitemid 34525079)
9. Arwert L, Roos JC, Lips P, Twisk JW, Manoliu RA, Drent ML 2005 Effects of 10 years of growth hormone (GH) replacement therapy in adult GH-deficient men. Clin Endocrinol (Oxf) 63:310-316 (Pubitemid 41233449)
10. Holmer H, Svensson J, Rylander L, Johannsson G, Rosén T, Bengtsson BA, Thorén M, Höybye C, Degerblad M, Bramnert M, Hägg E, Edén Engström B, Ekman B, Norrving B, Hagmar L, Erfurth EM 2007 Nonfatal stroke, cardiac disease, and diabetes mellitus in hypopituitary patients on hormone replacement including growth hormone. J Clin Endocrinol Metab 92:3560-3567 (Pubitemid 47439735)
11. Bengtsson BA, Abs R, Feldt-Rasmussen U, Goth M, Monson J, Thunander M, Koltowska-Häggström M, Mattsson A, Wilton P 2002 The risk of diabetes mellitus in hypopituitary patients on growth hormone substitution. Growth Horm IGF Res 12:302-303
12. Götherström G, Bengtsson BA, Bosaeus I, Johannsson G, Svensson J 2007 A 10-year, prospective study of the metabolic effects of growth hormone replacement in adults. J Clin Endocrinol Metab 92:1442-1445 (Pubitemid 46562361)
13. Luger A, Mattsson AF, Koltowska-Haggstrom M, Thunander M, Goth M, Verhelst J, Abs R 2010 Incidence of diabetes mellitus in growth hormone (GH) deficient patients during GH replacement therapy: an analysis of KIMS (Pfizer international metabolic database). Endocr Rev 31:S329 (Abstract P1-270)
14. Webb SM, Strasburger CJ, Mo D, Hartman ML, Melmed S, Jung H, Blum WF, Attanasio AF; HypoCCS International Advisory Board 2009 Changing patterns of the adult growth hormone deficiency diagnosis documented in a decade-long global surveillance database. J Clin Endocrinol Metab 94:392-399
15. Richesson RL, Fung KW, Krischer JP 2008 Heterogeneous but "standard" coding systems for adverse events: Issues in achieving interoperability between apples and oranges. Contemp Clin Trials 29:635-645
16. Anderson RN, Rosenberg HM 1998 Age standardization of death rates: implementation of the year 2000 standard. Natl Vital Stat Rep 47:1-16, 20
17. Breslow NE, Day NE 1987 Statistical methods in cancer research. Volume II. The design and analysis of cohort studies. IARC Sci Publ 82:65-69
18. National Cancer Institute Surveillance epidemiology and end results US standard population. seer.cancer.gov/stdpopulations/stdpop.19ages.html. Accessed January 8, 2011
19. Flegal KM, Carroll MD, Ogden CL, Curtin LR 2010 Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303:235-241
20. Geiss LS, Pan L, Cadwell B, Gregg EW, Benjamin SM, Engelgau MM 2006 Changes in incidence of diabetes in US adults, 1997-2003. Am J Prev Med 30:371-377
21. Thunander M, Petersson C, Jonzon K, Fornander J, Ossiansson B, Torn C, Edvardsson S, Landin-Olsson M 2008 Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden. Diabetes Res Clin Pract 82:247-255
22. Meisinger C, Döring A, Thorand B, Heier M, Löwel H 2006 Body fat distribution and risk of type 2 diabetes in the general population: are there differences between men and women? The MONICA/KORA Augsburg Cohort Study. Am J Clin Nutr 84:483-489 (Pubitemid 44713396)
23. Balkau B, Hillier T, Vierron E, D'Hour A, Lépinay P, Royer B, Born C 2005 Comment to: Borch-Johnsen K, Colagiuri S, Balkau B et al. (2004) Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia. Diabetologia 47:1396-1402.
24. Diabetologia 48:801-802
25. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB 2005 Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112:3066-3072 (Pubitemid 43113437)
26. Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C, Williams DE, Gregg EW, Bainbridge KE, Saydah SH, Geiss LS 2009 Full accounting of diabetes and pre-diabetes in the US population in 1988-1994 and 2005-2006. Diabetes Care 32:287-294
27. Achterberg PW, Kramers PG, van Oers HA 2008 European Community Health monitoring: the EUPHIX-model. Scand J Public Health 36:676-684
28. Shaw JE, Sicree RA, Zimmet PZ 2010 Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:4-14
29. Møller N, Jørgensen JO 2009 Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev 30:152-177
30. Webb SM, Mo D, Lamberts SWJ, Melmed S, Cavagnini F, Pecori Giraldi F, Strasburger CJ, Zimmermann AG, Woodmansee WW; International HypoCCS Advisory Board 2010 Metabolic, cardiovascular, and cerebrovascular outcomesin growth hormone-deficient subjects with previous Cushing's disease or non-functioning pituitary adenoma. J Clin Endocrinol Metab 95:630-638
31. Filipsson H, Monson JP, Koltowska-Häggström M, Mattsson A, Johannsson G 2006 The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients. J Clin Endocrinol Metab 91:3954-3961 (Pubitemid 44536870)
32. Rathmann W, Haastert B, Icks A, Löwel H, Meisinger C, Holle R, Giani G 2003 High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia 46:182-189 (Pubitemid 36343881)